1. Home
  2. BDRX vs OGEN Comparison

BDRX vs OGEN Comparison

Compare BDRX & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDRX
  • OGEN
  • Stock Information
  • Founded
  • BDRX 2000
  • OGEN 1996
  • Country
  • BDRX United Kingdom
  • OGEN United States
  • Employees
  • BDRX N/A
  • OGEN N/A
  • Industry
  • BDRX Biotechnology: Pharmaceutical Preparations
  • OGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • BDRX Health Care
  • OGEN Health Care
  • Exchange
  • BDRX Nasdaq
  • OGEN Nasdaq
  • Market Cap
  • BDRX 9.6M
  • OGEN 9.8M
  • IPO Year
  • BDRX N/A
  • OGEN N/A
  • Fundamental
  • Price
  • BDRX $0.80
  • OGEN $1.02
  • Analyst Decision
  • BDRX Strong Buy
  • OGEN
  • Analyst Count
  • BDRX 1
  • OGEN 0
  • Target Price
  • BDRX $8.00
  • OGEN N/A
  • AVG Volume (30 Days)
  • BDRX 4.2M
  • OGEN 146.5K
  • Earning Date
  • BDRX 04-19-2024
  • OGEN 08-12-2024
  • Dividend Yield
  • BDRX N/A
  • OGEN N/A
  • EPS Growth
  • BDRX N/A
  • OGEN N/A
  • EPS
  • BDRX N/A
  • OGEN N/A
  • Revenue
  • BDRX $482,278.00
  • OGEN $20,629.00
  • Revenue This Year
  • BDRX N/A
  • OGEN N/A
  • Revenue Next Year
  • BDRX N/A
  • OGEN N/A
  • P/E Ratio
  • BDRX N/A
  • OGEN N/A
  • Revenue Growth
  • BDRX N/A
  • OGEN N/A
  • 52 Week Low
  • BDRX $0.67
  • OGEN $0.97
  • 52 Week High
  • BDRX $9.64
  • OGEN $7.74
  • Technical
  • Relative Strength Index (RSI)
  • BDRX 42.17
  • OGEN 35.55
  • Support Level
  • BDRX $0.91
  • OGEN $1.00
  • Resistance Level
  • BDRX $1.20
  • OGEN $1.19
  • Average True Range (ATR)
  • BDRX 0.14
  • OGEN 0.07
  • MACD
  • BDRX 0.00
  • OGEN 0.02
  • Stochastic Oscillator
  • BDRX 9.48
  • OGEN 6.25

About BDRX Biodexa Pharmaceuticals plc American Depositary Shs

Biodexa Pharmaceuticals Plc is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and innovative drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.

Share on Social Networks: